Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, v3.5.5, was added to the study history, and the previous revision, v3.5.4, was removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe record history now displays Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor metadata update to the page's revision history rather than a change to study content.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision, v3.5.3, was added to the record history, replacing the previous revision, v3.5.2. This indicates an update to the page's version metadata.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision history now includes a new version v3.5.2 and removes the older v3.5.0.SummaryDifference0.1%

- Check72 days agoChange DetectedNew revision entry added: v3.5.0. The previous revision v3.4.3 is listed as deleted.SummaryDifference0.1%

- Check86 days agoChange DetectedSite revision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.1%

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.